PAMU
ZOM

Pictet Asset Management (UK)’s Zomedica Corp. ZOM Stock Holding History

Pictet Asset Management (UK)’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$43K Buy
+51,237
New +$47.7K ﹤0.01% 1742

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return
KFS
Kelly Financial Services Braintree, Massachusetts $467M AUM 21.13% 1-Year Est. Return

Pictet Asset Management (UK)'s ZOM Position: Q2 2021 in Review

Pictet Asset Management (UK) opened a new position in Zomedica Corp. (ZOM) in Q2 2021: 51,237 shares worth $43K. The stake represents ﹤0.01% of the portfolio and ranks #1742 among its holdings.

106 funds tracked by Wall St. Rank hold ZOM as of Q2 2021.

  • Pictet Asset Management (UK) held 51,237 shares of Zomedica Corp. worth $43K as of Q2 2021.
  • Zomedica Corp. was a new Pictet Asset Management (UK) position in Q2 2021.
  • Zomedica Corp. made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1742 holding.
  • 106 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.